|
|
Blood, Vol. 108, Issue 13, 4109-4117, December 15, 2006
Expression of tumor-associated antigens in acute myeloid leukemia: implications for specific immunotherapeutic approaches
Blood Greiner et al.
108: 4109
Supplemental materials for: Greiner et al, Vol 108, Issue 13, 4109-4118
Files in this Data Supplement:
- Table S1. Clinical, morphological, cytogenetic and molecular genetic information on 116 AML patient samples (PDF, 50.5 KB)
-
Updated clinical follow-up data for the previously published cDNA microarray-based gene expression data set from Bullinger et al,1 which was used to investigate the expression levels of relevant TAAs in adult AML. The corresponding gene expression data are publicly available in the Gene Expression Omnibus database (accession no. GSE425).
1. Bullinger L, Dohner K, Bair E, et al. Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N Engl J Med. 2004;350:1605-1616.
|
|
